OBJECTIVES: To prospectively investigate the effect of varying the injection flow rates of a saline chaser on vascular and parenchymal contrast enhancement during abdominal MDCT. METHODS:100 consecutive patients were randomly assigned to four injection protocols. A fixed dose of contrast medium was administered followed by no saline (Protocol A) or 50 mL of saline at 2, 4, or 8 mL/s (Protocols B, C, and D). Peak, time-to-peak, and duration of 90% peak enhancement were determined for aorta, pancreas, and liver. RESULTS:Aortic peak enhancement was significantly higher for Protocol D (369.5 HU) compared with Protocols A and B (332.9 HU and 326.0 HU, respectively; P < 0.05). Pancreatic peak enhancement was significantly higher for Protocols C and D (110.6 HU and 110.9 HU, respectively) compared to Protocol A (92.5 HU; P < 0.05). Aortic and pancreatic time-to-peak enhancement occurred significantly later for Protocol D compared with Protocol A (42.8 s vs. 36.1 s [P < 0.001] and 49.7 s vs. 45.3 s [P = 0.003]). CONCLUSIONS: Injecting a saline chaser at high flow rates yields significantly higher peak aortic and pancreatic enhancement, with a slight longer time-to-peak enhancement.
RCT Entities:
OBJECTIVES: To prospectively investigate the effect of varying the injection flow rates of a saline chaser on vascular and parenchymal contrast enhancement during abdominal MDCT. METHODS: 100 consecutive patients were randomly assigned to four injection protocols. A fixed dose of contrast medium was administered followed by no saline (Protocol A) or 50 mL of saline at 2, 4, or 8 mL/s (Protocols B, C, and D). Peak, time-to-peak, and duration of 90% peak enhancement were determined for aorta, pancreas, and liver. RESULTS: Aortic peak enhancement was significantly higher for Protocol D (369.5 HU) compared with Protocols A and B (332.9 HU and 326.0 HU, respectively; P < 0.05). Pancreatic peak enhancement was significantly higher for Protocols C and D (110.6 HU and 110.9 HU, respectively) compared to Protocol A (92.5 HU; P < 0.05). Aortic and pancreatic time-to-peak enhancement occurred significantly later for Protocol D compared with Protocol A (42.8 s vs. 36.1 s [P < 0.001] and 49.7 s vs. 45.3 s [P = 0.003]). CONCLUSIONS: Injecting a saline chaser at high flow rates yields significantly higher peak aortic and pancreatic enhancement, with a slight longer time-to-peak enhancement.
Authors: Florian F Behrendt; Philipp Bruners; Sebastian Keil; Cedric Plumhans; Andreas H Mahnken; Marco Das; Diana Ackermann; Rolf W Günther; Georg Mühlenbruch Journal: Eur J Radiol Date: 2009-04-05 Impact factor: 3.528
Authors: Courtney A Coursey; Rendon C Nelson; Paul W Weber; Laurens E Howle; Eli B Nichols; Daniele Marin; David DeLong Journal: AJR Am J Roentgenol Date: 2009-12 Impact factor: 3.959
Authors: Paul J Dorio; Fred T Lee; Kevin P Henseler; Mark Pilot; Myron A Pozniak; Thomas C Winter; Sarah A Shock Journal: AJR Am J Roentgenol Date: 2003-04 Impact factor: 3.959
Authors: Lisa L Chu; Bonnie N Joe; Antonio C A Westphalen; Emily M Webb; Fergus V Coakley; Benjamin M Yeh Journal: Radiology Date: 2007-10-02 Impact factor: 11.105
Authors: Helmut Schoellnast; Manfred Tillich; Hannes A Deutschmann; Michael J Deutschmann; Gerald A Fritz; Uwe Stessel; Gottfried J Schaffler; Martin M Uggowitzer Journal: J Comput Assist Tomogr Date: 2003 Nov-Dec Impact factor: 1.826